(Q33291585)

25 July 2017

Statistical validation of the criteria for symptom remission in schizophrenia: preliminary findings (English)

1 reference

25 July 2017

0 references

0 references

Mark G A Opler

1

1 reference

25 July 2017

Lawrence H Yang

series ordinal

2

1 reference

25 July 2017

Sue Caleo

series ordinal

3

1 reference

25 July 2017

Philip Alberti

series ordinal

4

1 reference

25 July 2017

24 July 2007

1 reference

25 July 2017

1 reference

25 July 2017

7

1 reference

25 July 2017

35

1 reference

Creative Commons Attribution 2.0 Generic

25 July 2017

start time

24 July 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-244x-7-35

0 references

cites work

The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1949820

Meeting everyday challenges: antipsychotic therapy in the real world

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1949820

Recovery from schizophrenia and the role of evidence-based psychosocial interventions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1949820

Factor structure and external validity of the PANSS revisited

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1949820

A pilot study of barriers to medication adherence in schizophrenia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1949820

The Risperidone Outcomes Study of Effectiveness (ROSE): a model for evaluating treatment strategies in typical psychiatric practice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1949820

Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1949820

A retrospective comparison of cumulative time spent in remission during treatment with olanzapine or risperidone among patients with schizophrenia

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-7-35

Direct transition to long-acting risperidone--analysis of long-term efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-7-35

Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-7-35

What does the PANSS mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-7-35

Acute-phase treatment in general hospitals: clinical psychopharmacologic evaluation in first-episode schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-7-35

Adherence and nonadherence to antipsychotic medications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-7-35

Are patients enrolled in first episode psychosis drug trials representative of patients treated in routine clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-7-35

Associations of symptoms, psychosocial function and hope with qualities of self-experience in schizophrenia: comparisons of objective and subjective indicators of health

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-7-35

Patient-based and clinician-based support for the remission criteria in schizophrenia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1949820

Validation of remission criteria for schizophrenia.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1949820

31 October 2018

Identifiers

DOI

10.1186/1471-244X-7-35

1 reference

Dimensions Publication ID

25 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-244x-7-35

9 September 2019

1 reference

25 July 2017

1 reference